The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Clinical features of late‐onset Pompe disease: A prospective cohort study
Abstract
The objective of this 12‐month study was to describe the clinical features of late‐onset Pompe disease and identify appropriate outcome measures for use in clinical trials. Assessments included quantitative muscle testing (QMT), functional activities (FAA), 6‐min walk test (6MWT), and pulmonary function testing (PFT). Percent predicted values indicated quantifiable upper and lower extremity weakness, impaired walking ability, and respiratory muscle weakness. Significant declines in arm and leg strength and pulmonary function were observed during the study period. The outcome measures were demonstrated to be safe and reliable. Symptom duration was identified as the best predictor of the extent of skeletal and respiratory muscle weakness. Muscle Nerve 38: 1236–1245, 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Acid a-Glucosidase Deficiency (Glycogenosis Type II, Pompe Disease)
Raben, N., Plotz, P., & Byrne, B. (2002) · Current Molecular Medicine · doi:10.2174/1566524024605789 · Cited by 241
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy
Escolar, D. M., Buyse, G., Henricson, E., Leshner, R., Florence, J., Mayhew, J., Tesi‐Rocha, C., Gorni, K., Pasquali, L., Patel, K. M., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20523 · Cited by 107
Cited by
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease
van der Ploeg, A. T., Clemens, P. R., Corzo, D., Escolar, D. M., Florence, J., Groeneveld, G. J., Herson, S., Kishnani, P. S., Laforet, P., Lake, S. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909859 · Cited by 745
Self-citationSchoser, B., Stewart, A., Kanters, S., Hamed, A., Jansen, J., Chan, K., Karamouzian, M., & Toscano, A. (2017) · Journal of Neurology · doi:10.1007/s00415-016-8219-8 · Cited by 259
Strothotte, S., Strigl-Pill, N., Grunert, B., Kornblum, C., Eger, K., Wessig, C., Deschauer, M., Breunig, F., Glocker, F. X., Vielhaber, S., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5275-3 · Cited by 256
van der Meijden, J. C., Kruijshaar, M. E., Harlaar, L., Rizopoulos, D., van der Beek, N. A. M. E., & van der Ploeg, A. T. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0166-3 · Cited by 37
“In untreated adult patients and children, FVC has been reported to decline between 1 pp. and 5.5 pp. per year (Wokke et al 2008; van Capelle et al 2010; van der Ploeg et al 2010; van der Beek et al 2011; de Vries et al 2012; van der Beek et al 2012).”
BackgroundResultInfluential
Metadata
- Authors
- Wokke, J. H. J., Escolar, D. M., Pestronk, A., Jaffe, K. M., Carter, G. T., van den Berg, L. H., Florence, J. M., Mayhew, J., Skrinar, A., Corzo, D., & Laforet, P.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2008-09-24
- Volume
- 38
- Issue
- 4
- Pages
- 1236-1245
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W1973983918
- Cited by
- 175
- References
- 4
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.